Bioplatinum Technologies

Bioplatinum is a South Korean biotechnology company specializing in the development of next-generation cancer immunotherapies and drug delivery systems. The company utilizes its proprietary platinum-based nanoparticle technology to enhance the efficacy and reduce the toxicity of traditional chemotherapeutics. Their lead programs focus on modulating the tumor microenvironment to improve the response to immune checkpoint inhibitors. Bioplatinum aims to provide innovative solutions for hard-to-treat solid tumors through its unique platform. The company's approach combines nanotechnology with immunology to create synergistic effects in oncology treatment.